Lyell Immunopharma Files Q1 2025 10-Q
Ticker: LYEL · Form: 10-Q · Filed: May 13, 2025 · CIK: 1806952
| Field | Detail |
|---|---|
| Company | Lyell Immunopharma, Inc. (LYEL) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Lyell Immunopharma filed its Q1 2025 10-Q, check financials.
AI Summary
Lyell Immunopharma, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance sheet items and changes in equity. Specific dollar amounts and dates related to financial statements are presented within the report.
Why It Matters
This filing provides investors with the latest financial snapshot of Lyell Immunopharma, Inc., crucial for understanding the company's performance and financial health in early 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Players & Entities
- Lyell Immunopharma, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date of the report
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 13, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001806952.
What is Lyell Immunopharma's Standard Industrial Classification (SIC) code?
Lyell Immunopharma's SIC code is 2834, for Pharmaceutical Preparations.
What is the company's business address?
The company's business address is 201 Haskins Way, South San Francisco, CA 94080.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Lyell Immunopharma, Inc. (LYEL).